News &

Press

venBio news

“venBio Raises $550 Million Venture Capital Fund Focused on Life Sciences.”

“venBio Closes $394 Million Life Sciences Venture Capital Fund.”

Portfolio news

ALX Oncology Reports Positive Interim Phase 2 ASPEN-06 Clinical Trial Results

Oct 3, 2023

RayzeBio Announces Closing of Upsized $358 Million IPO

Sep 19, 2023

Introducing Fierce Biotech’s 2023 Fierce 15 – FOG and RayzeBio

Aug 28, 2023

Artiva Biotherapeutics Announces FDA Clearance of IND for AlloNK® Cell Therapy Candidate in Combination with Rituximab in Lupus Nephritis

Aug 16, 2023

ImmPACT Bio Announces FDA Clearance of IND Application

Aug 15, 2023

Attovia Therapeutics Launches with $60 Million Series A Financing to Unlock Potential of Novel Biparatopic Nanobody Platform

Jun 20, 2023

Abdera Therapeutics Debuts With $142 Million in Financing to Engineer and Advance Best-in-Class Antibody-Based Radiopharmaceuticals for Cancer

Apr 20, 2023

San Francisco office

1700 Owens Street, Suite 595
San Francisco, CA 94158

Seattle office

1200 Westlake Ave N, Suite 900
Seattle, WA 98109

© 2023 venBio. All Rights Reserved.